Home › Funds › Future Fund LLC › IONS
Future Fund LLC position in IONS
IONIS PHARMACEUTICALS INC · Health Care
Future Fund LLC reported holding 71,362 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$5.7M, representing 1.62% of its reported portfolio and ranking #11 among its reported holdings. Future Fund LLC has disclosed IONS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Future Fund LLC's IONS position evolved
Future Fund LLC first disclosed a stake in IONS in Q2 2025 at 29,595 shares (US$1.2M). The position peaked in Q2 2026 at 71,362 shares, worth US$5.7M. Across 5 filings, Future Fund LLC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 71,362 shares valued at US$5.7M — an increase of 12,630 shares quarter over quarter.. Notable position changes include a 27% increase in Q4 2025 (shares fell 5% over the following quarter), a 28% increase in Q1 2026 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 29.59K | $1.17M | New |
| Q3 2025 | 36.16K | $2.37M | Add |
| Q4 2025 | 45.85K | $3.63M | Add |
| Q1 2026 | 58.73K | $4.41M | Add |
| Q2 2026 | 71.36K | $5.66M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IONS and 13F data
IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IONS
- Two Sigma Investments 6.25M sh · $495.75M · Q2 2026
- TWO SIGMA ADVISERS, LP 3.05M sh · $241.45M · Q4 2025
- Tweedy, Browne Co LLC 2.28M sh · $180.81M · Q2 2026
- Deep Track Capital, LP 2.20M sh · $174.44M · Q2 2026
- BAKER BROS. ADVISORS LP 2.05M sh · $162.36M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 94.68M sh · $147.77M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 60.00M sh · $93.10M · Q2 2026
- Bellevue Group AG 972.26K sh · $77.09M · Q2 2026
- GROUPAMA ASSET MANAGMENT 937.08K sh · $75.20M · Q2 2026
- Davern Capital Partners, LP 798.71K sh · $63.33M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 787.26K sh · $62.42M · Q2 2026
- Eversept Partners, LP 664.68K sh · $52.70M · Q2 2026
More on Future Fund LLC
FAQ
How long has Future Fund LLC held IONS?
Future Fund LLC has disclosed IONS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Future Fund LLC's current position in IONS?
As of Q2 2026, Future Fund LLC holds 71.36K shares of IONS (IONIS PHARMACEUTICALS INC), valued at $5.66M, representing 1.62% of its reported portfolio and ranking #11.
Has Future Fund LLC been buying or selling IONS?
In the latest 13F filing (Q2 2026), Future Fund LLC increased its position in IONS. The position peaked in Q2 2026 at 71.36K shares.
Which other funds hold IONS?
Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.